Back to News
Nov 26, 2025 12:00 PM

What's Going On With Johnson & Johnson Stock On Wednesday?

Johnson & Johnson (NYSE:JNJ) stock has surged almost 42.9% in the year to date, approximately 35% in 6 months, and 8.6% in one month.

JNJ is trading at elevated levels. See what the experts say here.

The rally streak reflects strong third-quarter earnings, deals like the Halda Therapeutics acquisition, as well as positive FDA label expansions.

Recent Earnings Report

During its most recent quarterly earnings, Johnson & Johnson announced plans to separate its Orthopedics business to enhance strategic and operational focus.

The transaction would establish a standalone orthopedics business, operating as DePuy Synthes. Johnson & Johnson aims to complete the project within 18 to 24 months.

The company reported a third-quarter 2025 adjusted earnings of $2.80 per share, up 15.7% year over year, beating the consensus of ...